John Groopman | Academic Influence

John Groopman's AcademicInfluence.com Rankings

John Groopman

Biology

#9391

World Rank

#12592

Historical Rank

Molecular Biology

#1279

World Rank

#1306

Historical Rank

biology Degrees

Download Badge

Biology

John Groopman's Degrees

Bachelors Biology University of California, Berkeley
PhD Molecular Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is John Groopman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John D. Groopman is an American cancer researcher. Groopman completed his bachelor's degree at Elmira College in 1974, then obtained a doctorate in toxicology from the Massachusetts Institute of Technology in 1979. He remained at MIT for postdoctoral research, and subsequently worked for the National Cancer Institute within the Laboratory of Human Carcinogenesis. Groopman served as the Anna M. Baetjer Professor and Chair of the Department of Environmental Health Sciences at the Johns Hopkins Bloomberg School of Public Health, and later the Edyth H. Schoenrich Professorship in Preventive Medicine. In 2010, Groopman received the Award for Excellence in Cancer Prevention Research jointly awarded by the American Association for Cancer Research and the Prevent Cancer Foundation.

(See a Problem?)

John Groopman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity (2001) (709)
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma (1992) (677)
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. (1994) (665)
Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. (2011) (560)
Workgroup Report: Public Health Strategies for Reducing Aflatoxin Exposure in Developing Countries (2006) (496)
Public health impacts of foodborne mycotoxins. (2014) (415)
The toxicology of aflatoxins: human health, veterinary and agricultural significance. (1993) (375)
DNA damage by mycotoxins. (1999) (351)
Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. (1999) (320)
Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer (2001) (304)
Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. (2013) (284)
Effects of Glucosinolate-Rich Broccoli Sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, People's Republic of China (2005) (283)
Aflatoxin exposure in human populations: measurements and relationship to cancer. (1988) (266)
Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. (2008) (263)
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. (2001) (251)
Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. (1987) (233)
Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. (1993) (226)
Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. (1992) (220)
Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. (1997) (216)
Translational strategies for cancer prevention in liver (2003) (213)
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. (1992) (207)
Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. (1988) (206)
Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. (1998) (203)
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. (2006) (197)
Mycotoxin Control in Low- and Middle-income Countries (2016) (191)
Diet and carcinogenesis. (1993) (185)
Bioavailability of Sulforaphane from Two Broccoli Sprout Beverages: Results of a Short-term, Cross-over Clinical Trial in Qidong, China (2011) (176)
Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. (1986) (176)
Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. (1985) (175)
Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. (2001) (173)
Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. (1991) (172)
Specific mutations of hepatitis B virus in plasma predict liver cancer development. (2004) (168)
Development of cancer chemopreventive agents: oltipraz as a paradigm. (1999) (167)
Factors affecting Aspergillus flavus group infection and aflatoxin contamination of crops. (1993) (160)
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances (2019) (157)
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. (2001) (154)
Acute hepatotoxicity of aflatoxins. (1993) (152)
Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. (1985) (150)
Rapid and Sustainable Detoxication of Airborne Pollutants by Broccoli Sprout Beverage: Results of a Randomized Clinical Trial in China (2014) (143)
Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A (1999) (140)
Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. (1985) (139)
Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. (1995) (139)
Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. (2004) (138)
Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men (1993) (130)
The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? (1999) (130)
In vitro reactions of aflatoxin B1-adducted DNA. (1981) (128)
Children's health and the environment: a new agenda for prevention research. (1998) (128)
Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. (1992) (126)
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. (1997) (125)
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. (1996) (124)
Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. (1992) (123)
High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. (1984) (120)
Respiratory aflatoxicosis: suppression of pulmonary and systemic host defenses in rats and mice. (1994) (120)
Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review (2012) (116)
Role of metabolism and viruses in aflatoxin-induced liver cancer. (2005) (116)
Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1. (1992) (114)
Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. (2012) (114)
Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. (1994) (113)
Reduced Aflatoxin Exposure Presages Decline in Liver Cancer Mortality in an Endemic Region of China (2013) (112)
Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. (1993) (108)
Statistical inference from multiple iTRAQ experiments without using common reference standards. (2013) (107)
Exposure to aflatoxin and fumonisin in children at risk for growth impairment in rural Tanzania (2018) (107)
Aflatoxin and liver cancer. (1999) (106)
Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. (1992) (105)
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. (2001) (104)
Dietary Acrylamide and Human Cancer: A Systematic Review of Literature (2014) (103)
Approaches to reduction of aflatoxins in foods and feeds. (1993) (103)
Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. (1992) (102)
Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. (1993) (101)
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. (2003) (99)
Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry. (2006) (95)
Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin B₁-lysine albumin biomarkers. (2014) (95)
Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. (2005) (88)
Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat. (2007) (87)
The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. (1990) (86)
cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. (1999) (86)
Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat. (1988) (85)
11 – Epidemiology of Aflatoxin-Related Disease (1993) (82)
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations (1999) (82)
Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. (1999) (81)
Preneoplastic Prostate Lesions (2001) (79)
Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. (1992) (79)
Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. (1992) (79)
Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin treated intact but not ovariectomized rats. (1996) (78)
An automated, handheld biosensor for aflatoxin. (2000) (78)
2 – Biochemical Mechanisms and Biological Implications of the Toxicity of Aflatoxins as Related to Aflatoxin Carcinogenesis (1993) (75)
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. (2019) (75)
Human Aflatoxin Albumin Adducts Quantitatively Compared by ELISA, HPLC with Fluorescence Detection, and HPLC with Isotope Dilution Mass Spectrometry (2008) (73)
Association of aflatoxin with gallbladder cancer in Chile. (2015) (72)
Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. (1981) (71)
Molecular biomarkers for aflatoxins and their application to human cancer prevention. (1994) (71)
Approaches to environmental exposure assessment in children. (1998) (69)
Analysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometry. (2005) (69)
Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. (1987) (68)
Lack of specificity of trans,trans-muconic acid as a benzene biomarker after ingestion of sorbic acid-preserved foods. (2000) (67)
Hepatitis B 1762T/1764A Mutations, Hepatitis C Infection, and Codon 249 p53 Mutations in Hepatocellular Carcinomas from Thailand (2005) (66)
Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. (2011) (66)
Complete Protection against Aflatoxin B1-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold (2014) (66)
Prospective Evaluation of Hepatitis B 1762T/1764A Mutations on Hepatocellular Carcinoma Development in Shanghai, China (2009) (64)
Antibody-antigen binding in organic solvents. (1989) (62)
Quantitative Comparison of Aflatoxin B1 Serum Albumin Adducts in Humans by Isotope Dilution Mass Spectrometry and ELISA (2006) (60)
Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. (2001) (58)
Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death (2004) (58)
Genotyping by mass spectrometric analysis of short DNA fragments (1998) (57)
Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008) (55)
Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. (1997) (55)
Long-term Stability of Human Aflatoxin B1 Albumin Adducts Assessed by Isotope Dilution Mass Spectrometry and High-Performance Liquid Chromatography–Fluorescence (2008) (55)
Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry. (2006) (52)
Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo. (1980) (52)
Benzene exposure, assessed by urinary trans,trans-muconic acid, in urban children with elevated blood lead levels. (1996) (52)
Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis (2012) (51)
Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. (1996) (50)
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin. (2008) (50)
12 – Molecular Dosimetry Methods for Assessing Human Aflatoxin Exposures (1993) (50)
Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology. (1992) (50)
The Plasma Proteome Identifies Expected and Novel Proteins Correlated with Micronutrient Status in Undernourished Nepalese Children (2013) (49)
16 – Veterinary Diseases Related to Aflatoxins (1993) (49)
Association of Aflatoxin and Gallbladder Cancer. (2017) (49)
Epidemiology of human aflatoxin exposures and their relationship to liver cancer. (1996) (48)
Distribution of aflatoxins in tissues of growing pigs fed an aflatoxin-contaminated diet amended with a high affinity aluminosilicate sorbent. (1990) (47)
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. (2012) (46)
Environmental tobacco smoke exposure in inner-city children. (1996) (46)
Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. (1982) (45)
Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats. (2001) (45)
Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. (1995) (44)
Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence (2017) (44)
Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations (1991) (44)
Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man. (1998) (44)
The direct glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) by human and rabbit liver microsomes. (1993) (44)
Molecular biomarkers for human chemical carcinogen exposures. (1993) (43)
4 – Pharmacokinetics and Excretion of Aflatoxins (1993) (43)
Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct. (1994) (43)
Aflatoxin, a human carcinogen: determination in foods and biological samples by monoclonal antibody affinity chromatography. (1988) (42)
Quantitative Analysis of Plasma TP53 249Ser-Mutated DNA by Electrospray Ionization Mass Spectrometry (2005) (42)
Revisiting the tumorigenesis timeline with a data-driven generative model (2019) (42)
Synthesis and characterization of aflatoxin B1 mercapturic acids and their identification in rat urine. (1997) (42)
Increased Hepatic Oxidative DNA Damage in Patients with Hepatocellular Carcinoma (2001) (41)
Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally (2014) (40)
Aflatoxin exposure during the first 36 months of life was not associated with impaired growth in Nepalese children: An extension of the MAL-ED study (2017) (40)
23 – Economic Issues Associated with Aflatoxins (1993) (39)
Development of Aflatoxin B1-Lysine Adduct Monoclonal Antibody for Human Exposure Studies (2001) (39)
Comparison Study on the Complete Sequence of Hepatitis B Virus Identifies New Mutations in Core Gene Associated with Hepatocellular Carcinoma (2010) (38)
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China (1997) (37)
Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells. (2013) (37)
5 – Nonhepatic Disposition and Effects of Aflatoxin B1 (1993) (36)
Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1. (2003) (36)
NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice (2017) (36)
Biomarkers and mechanistic approaches in environmental epidemiology. (1995) (36)
Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry. (2006) (36)
Seasonal Variation in TP53 R249S-Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection (2011) (35)
Absence of TP53 Codon 249 Mutations in Young Guinean Children with High Aflatoxin Exposure (2005) (35)
Biomarkers for assessing environmental exposure to carcinogens in the diet. (1995) (35)
Aflatoxins isolated by immunoaffinity chromatography from foods consumed in The Gambia, West Africa. (1992) (35)
Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma. (2011) (34)
DNA Methylation as a Cancer‐Specific Biomarker (2003) (34)
Toxicological resources for cumulative risk: an example with hazardous air pollutants. (2004) (33)
9 – Aflatoxin Carcinogenesis in the Context of the Multistage Nature of Cancer (1993) (33)
Early Life Metabolism of Bisphenol A: A Systematic Review of the Literature (2014) (32)
Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO‐Im (2017) (32)
Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China. (2011) (31)
Strategies for chemoprevention of liver cancer. (2002) (31)
Mechanisms of chemoprotection by oltipraz (1992) (31)
DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice. (2006) (31)
Mass spectrometry for genotyping: an emerging tool for molecular medicine. (2000) (31)
Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis. (2004) (30)
Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3. (2008) (30)
Prenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change (2014) (30)
15 – Mycological Aspects of Aflatoxin Formation (1993) (29)
Repair of aflatoxin B1 DNA adducts by the UvrABC endonuclease of Escherichia coli. (1993) (29)
DNA methylation as a cancer-specific biomarker: from molecules to populations. (2003) (29)
Quantitative analysis of aflatoxin-albumin adducts. (1993) (29)
Human exposure monitoring and evaluation in the Arctic: the importance of understanding exposures to the development of public health policy. (2004) (28)
Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis). (2000) (27)
Urinary free bisphenol A and bisphenol A-glucuronide concentrations in newborns. (2013) (27)
7 – Role of Aflatoxin–DNA Adducts in the Cancer Process (1993) (27)
Broccoli sprout beverage is safe for thyroid hormonal and autoimmune status: Results of a 12-week randomized trial. (2019) (26)
Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli (1988) (26)
Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand. (2013) (26)
Plasma Proteome Biomarkers of Inflammation in School Aged Children in Nepal (2015) (25)
In vivo activation of aflatoxin B1 in C57BL/6N mice carrying a human fetus-specific CYP3A7 gene. (1997) (25)
Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer (1996) (25)
Qidong: a crucible for studies on liver cancer etiology and prevention (2019) (25)
Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat. (2009) (25)
Dietary Aflatoxin-Induced Stunting in a Novel Rat Model: Evidence for Toxin-Induced Liver Injury and Hepatic Growth Hormone Resistance (2015) (24)
Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl. (1988) (24)
Aflatoxins in milk. (1993) (24)
Synthesis of 5,5,6,6-D4-L-lysine-aflatoxin Bl for use as a mass spectrometric internal standard (2004) (24)
Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1. (2014) (23)
Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice. (2014) (23)
Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry. (2008) (23)
Aflatoxin-DNA adduct formation in chronically dosed rats fed a choline-deficient diet. (1990) (23)
General intelligence is associated with subclinical inflammation in Nepalese children: A population-based plasma proteomics study (2016) (22)
Aflatoxin B1--DNA adduct formation in rat liver following exposure by aerosol inhalation. (1992) (22)
Urinary 6 beta-hydroxycortisol/cortisol ratios measured by high-performance liquid chromatography for use as a biomarker for the human cytochrome P-450 3A4. (1992) (22)
Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival (2011) (22)
Commentary: Children's Health and the Environment: A New Agenda for Prevention Research (1998) (22)
Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex. (2011) (21)
Use of carcinogen-DNA and carcinogen-protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trials. (1996) (21)
Chronic aflatoxin exposure in children living in Bhaktapur, Nepal: Extension of the MAL-ED study (2017) (21)
Mechanism of Protection against Aflatoxin Tumorigenicity in Rats Fed 5-(2-Pyrazinyl)-4-methyl-l,2-dithiol-3-thione (Oltipraz) and Related l,2-Dithiol-3-thiones and l (1987) (21)
Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal. (2012) (21)
SHORT COMMUNICATION: Inhibition of aflatoxin M1 excretion in rat urine during dietary intervention with oltipraz (1996) (20)
The association of sex steroid hormone concentrations with non‐alcoholic fatty liver disease and liver enzymes in US men (2020) (19)
A Plasma α-Tocopherome Can Be Identified from Proteins Associated with Vitamin E Status in School-Aged Children of Nepal. (2015) (19)
Elevated HPRT mutation frequencies in aflatoxin-exposed residents of daxin, Qidong county, People's Republic of China. (1999) (19)
Variability of molecular biomarker measurements from nonlinear calibration curves. (1996) (19)
Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States? (1999) (19)
Chemoprotection by inducers of electrophile detoxication enzymes. (1993) (18)
Association between aflatoxin-albumin adduct levels and tortilla consumption in Guatemalan adults (2019) (18)
Acceleration to Death from Liver Cancer in People with Hepatitis B Viral Mutations Detected in Plasma by Mass Spectrometry (2007) (18)
Biomarkers of Exposure, Effect, and Susceptibility (2010) (18)
Novel Natural Mutations in the Hepatitis B Virus Reverse Transcriptase Domain Associated with Hepatocellular Carcinoma (2014) (18)
Formation of two novel estrogen guanine adducts and HPLC/MS detection of 4-hydroxyestradiol-N7-guanine in human urine. (2008) (17)
The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1. (1987) (17)
Dose-dependent detoxication of the airborne pollutant benzene in a randomized trial of broccoli sprout beverage in Qidong, China. (2019) (17)
The Plasma Proteome Is Associated with Anthropometric Status of Undernourished Nepalese School-Aged Children123 (2017) (17)
Molecular Tools and Infectious Disease Epidemiology (2011) (17)
High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. (2019) (16)
Aflatoxin exposure in children living in Mirpur, Dhaka: data from MAL-ED companion study (2018) (16)
Serial Free Bisphenol A and Bisphenol A Glucuronide Concentrations in Neonates. (2015) (16)
Unique pulmonary immunotoxicological effects of urban PM are not recapitulated solely by carbon black, diesel exhaust or coal fly ash (2018) (16)
Carcinogen‐DNA and protein adducts: Biomarkers for cohort selection and modifiable endpoints in chemoprevention trials (1996) (15)
Chemoprotection by l,2-Dithiole-3-thiones (1993) (15)
Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz. (1996) (15)
Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP. (2002) (15)
Measurement of aflatoxin and aflatoxin metabolites in urine by liquid chromatography-tandem mass spectrometry. (2007) (15)
Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution. (2018) (15)
Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali (2015) (15)
Molecular epidemiology and human risk monitoring. (1995) (14)
Recent methods of analysis for aflatoxins in foods and feeds. (1993) (14)
Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. (1992) (13)
Transferases S Role of Induction of Glutathione Ethoxyquin : Formation , and Hepatic Tumorigenesis in Rats Fed-guanine 7 N Modulation of Aflatoxin Metabolism , Aflatoxin-Updated Version (2006) (13)
Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer. (2018) (13)
Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala (2020) (12)
A single neonatal exposure to aflatoxin b1 induces prolonged genetic damage in two loci of mouse liver. (2012) (12)
Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver (2017) (12)
8 – Mechanisms by Which Aflatoxins and Other Bulky Carcinogens Induce Mutations (1993) (12)
Problems associated with accurately measuring aflatoxin in food and feeds: errors associated with sampling, sample preparation and analysis. (1993) (12)
Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma (2013) (12)
Molecular biomarkers for aflatoxins and their application to human liver cancer. (1995) (12)
Commentary: Approaches to Environmental Exposure Assessment in Children (1998) (12)
Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment? (1988) (11)
Analytical methods for assessing exposure to 4-aminobiphenyl based on protein adduct formation. (1986) (11)
Biological Systems of Vitamin K: A Plasma Nutriproteomics Study of Subclinical Vitamin K Deficiency in 500 Nepalese Children (2016) (11)
Interaction of aflatoxin B2 with rat liver DNA and histones in vivo. (1981) (11)
Detection and Concentration of Plasma Aflatoxin Is Associated With Detection of Oncogenic Human Papillomavirus in Kenyan Women (2019) (11)
10 – Nutritional Modulation of Aflatoxin Carcinogenesis (1993) (11)
22 – Human Risk Assessment Based on Animal Data: Inconsistencies and Alternatives (1993) (11)
Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case–control study (2020) (10)
Interactions of Fungal and Plant Toxins with DNA: Aflatoxins, Sterigmatocystin, Safrole, Cycasin, and Pyrrolizidine Alkaloids (1990) (10)
Inflammation throughout pregnancy and fetal growth restriction in rural Nepal (2019) (9)
Food Safety: Mycotoxins – Occurrence and Toxic Effects (2013) (9)
Molecular dosimetry of aflatoxin B1 exposures in a human population with high hepatitis B virus infection. (1990) (9)
A Non-Tumorigenic Human Liver Epithelial Cell Culture Model for Chemical and Biological Carcinogenesis Investigations (1991) (9)
Plasma Selenium Protein P Isoform 1 (SEPP1): A Predictor of Selenium Status in Nepalese Children Detected by Plasma Proteomics. (2017) (9)
Is It Time to Advance the Chemoprevention of Environmental Carcinogenesis with Microdosing Trials? (2009) (9)
Biomonitoring of Ambient Outdoor Air Pollutant Exposure in Humans Using Targeted Serum Albumin Adductomics. (2021) (9)
Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001–2010 (2019) (8)
Serum miR‐182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats (2019) (8)
Phage display of ScFv peptides recognizing the thymidine(6-4)thymidine photoproduct. (2000) (8)
Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala (2022) (8)
Liver cancer mortality over six decades in an epidemic area: what we have learned (2020) (8)
CONTACT DERMATITIS DUE TO THIAMINE: Report of Two Cases (1950) (8)
Monoclonal antibodies and rabbit antisera recognizing 4-aminobiphenyl--DNA adducts and application to immunoaffinity chromatography. (1992) (8)
Plasma proteins associated with circulating carotenoids in Nepalese school-aged children☆ (2018) (8)
Does aflatoxin B 1 play a role in the etiology of hepatocellular carcinoma in the United States (1999) (8)
Immunoaffinity-based phosphorescent sensor platform for the detection of bacterial spores (2000) (7)
Biomarkers and surrogacy: relevance to chemoprevention. (2001) (7)
Aflatoxin exposure was not associated with childhood stunting: results from a birth cohort study in a resource-poor setting of Dhaka, Bangladesh (2020) (6)
CHAPTER 4. Effects of aflatoxins and fumonisins on child growth (2015) (6)
Fluorescence quantification of aflatoxin N7-guanine adducts. (1994) (6)
Enzyme-mediated dialdehyde formation: an alternative pathway for benzo[a]pyrene 7,8-dihydrodiol bioactivation. (2000) (5)
Aflatoxin and Hepatocellular Carcinoma (2011) (5)
Chemoprevention of hepatic cancer in aflatoxin endemic areas (2012) (5)
Development of an automated handheld immunoaffinity fluorometric biosensor (2000) (5)
Novel Plasma Proteins in Nepalese School-aged Children are Associated with a Small Head Size at Birth (2017) (5)
Effect of 1,2-dithiole-3-thione, a monofunctional enzyme inducer, on aflatoxin-DNA adduct formation in rat liver. (1990) (5)
In vitro reactions of aflatoxin Bl-adducted DNA ( high-pressure liquid chromatography / carcinogen-nucleic acid interactions ) (5)
Aflatoxin B 1-DNA Adduct Formation and Mutagenicity in Livers of Neonatal Male and Female B 6 C 3 F 1 Mice (2011) (5)
The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate. (2002) (5)
Plasma proteome correlates of lipid and lipoprotein: biomarkers of metabolic diversity and inflammation in children of rural Nepal[S] (2018) (5)
Aflatoxin: A Global Public Health Problem (2016) (4)
Carcinogen-DNA and protein adducts as intermediate biomarkers for human chemoprotection trials. (1994) (4)
Mobilization of Environmental Toxicants Following Bariatric Surgery (2019) (4)
Biomarkers in environmental health research & practice. (1999) (4)
Mechanisms of Chemoprotection by 1,2-Dithiole-3-Thiones (1996) (4)
Aflatoxin and the Etiology of Liver Cancer and Its Implications for Guatemala. (2021) (4)
Quantitation of Aflatoxin B,-modified DMA Using Monoclonal Antibodies1 (1982) (4)
Aflatoxin, Hepatitis B Virus and Liver Cancer: A Paradigm for Molecular Epidemiology (2008) (3)
Prevention of liver cancer in Qidong, China: Lessons from aflatoxin biomarker studies (2013) (3)
Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross‐sectional study (2016‐2017) (2020) (3)
Immunoaffinity-Based Monitoring of Human Exposure to Aflatoxins in China and Gambia (1990) (3)
Mechanisms of Chemoprotection against Aflatoxin-Induced Hepatocarcinogenesis by Oltipraz (1991) (3)
Highlight Article: Environmental health in the biology century: Transitions from population to personalized prevention (2019) (3)
Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. (2019) (3)
Molecular Epidemiology and Biomarkers (2001) (3)
Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population (2022) (2)
Pigmented purpuric lichenoid dermatitis: its possible pathogenesis and report of a case. (1951) (2)
Assessing the Validity of Normalizing Aflatoxin B1-Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies (2022) (2)
FOOD SAFETY | Mycotoxins (2005) (2)
Pregnancy Alters Aflatoxin B 1 Metabolism and Increases DNA Damage in Mouse Liver (2017) (2)
Symposium of the Canadian Federation of Biological Societies / Symposium de la fédération canadienne des sociétés de biologie Molecular biomarkers for aflato×ins: from adducts to gene mutations to human liver cancer (1996) (2)
Application of monoclonal antibodies and dietary antioxidant-based animal models to define human exposure to aflatoxin B1. (1987) (2)
Inhibition of aflatoxin-induced liver cancer in the rat by oltipraz, 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione. (1990) (2)
Seasonal Variation in TP 53 R 249 S-Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection (2020) (2)
Improving nutrition and immunity with dry chain and integrated pest management food technologies in LMICs (2020) (1)
Abstract LB-405: Modulation of the metabolism of air-borne pollutants by broccoli sprout beverages: Results of a short term, cross-over clinical trial in Qidong, People's Republic of China (2011) (1)
Disease Prevention Research at NIH: An Agenda for All. Workshop C: The ambient environment--monitoring effects and initiating change. (1994) (1)
Association Between Liver Fibrosis and Serum Prostate Specific Antigen (PSA) 1 Among US Men: National Health and Nutrition Examination Survey (NHANES) 2 2001–2010 (2019) (1)
CHAPTER 3. Effects of aflatoxins on aflatoxicosis and liver cancer (2015) (1)
Letter: association of circulating bile acid concentrations and non‐alcoholic fatty liver disease—authors’ reply (2022) (1)
DNA adducts of nitropyrene detected by specific antibodies. (1987) (1)
Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B1 as a Risk Factor for HIV Transmission and Pathogenesis (2021) (1)
of Aflatoxin N7-Guanine Adducts (1994) (1)
Fluorescence − High-Performance Liquid Chromatography Assessed by Isotope Dilution Mass Spectrometry and Albumin Adducts 1 Long-term Stability of Human Aflatoxin (2008) (1)
Polyclonal and monoclonal antibodies recognizing 4-amino-biphenyl (4ABP) and its DNA adducts (1985) (1)
Abstract 1381: Reduction in aflatoxin exposure drives decrease in primary liver cancer in Qidong, China. (2013) (1)
CHAPTER 5. Fetal and neonatal toxicities of aflatoxins and fumonisins (2015) (1)
Distribution and time course of aflatoxin B1 binding in rat liver nuclei and identification of histone 1 as a major site of aflatoxin B1 adduction to rat liver chromosomal proteins in vivo (1979) (1)
Aflatoxin biomarkers (1992) (1)
Carcinogen monitoring by DNA adduct methodology in humans: clinical perspectives for the 1990s. (1989) (1)
Decreased oxidative DNA damage and accelerated cell turnover in woodchuck hepatitis virus infected liver. (2003) (1)
Abstract 5401: Dysregulated microRNAs in aflatoxin-induced hepatocellular carcinoma: Serum miR-182 as a potential predictive biomarker (2018) (1)
Mycotoxin Control in Low- and Middle- (2015) (1)
Associations between aflatoxin B1 ‐albumin adduct levels with metabolic conditions in Guatemala: A cross‐sectional study (2022) (1)
Sulforaphane-Mediated Reduction of Aflatoxin B-1-N7-Guanine in Rat Liver DNA : Impacts of Strain and Sex Citation (2014) (1)
Longitudinal Assessment of Prenatal, Perinatal, and Early-Life Aflatoxin B1 Exposure in 828 Mother–Child Dyads from Bangladesh and Malawi (2022) (1)
Association of detection of aflatoxin in plasma of Kenyan women with increased detection of oncogenic HPV. (2019) (1)
Cyclohexanone Exposure in Children on Extracorporeal Membrane Oxygenation Support (2021) (1)
Predictive power of hepatitis B viral mutations in plasma of chronic carriers for liver cancer development. (2006) (1)
Aflatoxin Exposure, Human Liver Cancer Risk, and Chemoprevention (2018) (1)
Comparison of Metabolic Risk Factors for Liver Cancer Among Men and Women in Guatemala (2017) (1)
A Summary of the Workshop “Applying Biomarkers to Occupational Health Practice” (2004) (1)
Cancers by Etiologically Defined Carcinogens Gene Mutational Hotspots in Human p 53 Selective Targeting of Updated (2006) (1)
Short Oligonucleotide Mass Analysis (SOMA) (2001) (0)
Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens (serum-free medium/aflatoxin Bs/benzo(alpyrene/N-nitrosodimethylamine) (2016) (0)
Abstract 4247: Quantitative measurement of aflatoxin-serum albumin adducts reveals substantial exposure in Guatemala, a country with high rates of liver cancer mortality in men and women (2017) (0)
A proteomic approach identifies plasma proteins correlated with vitamin B6 in Nepalese children (804.14) (2014) (0)
Use of Aflatoxin-DNA and Protein Adducts for Human Dosimetry (1990) (0)
Abstract ED02-01: Quantitative mass spectrometry for small molecules and gene mutations (2008) (0)
Effect of Antenatal Micronutrient Supplementation on the Plasma Proteome in School Aged Children in Nepal (2015) (0)
Protective role of NRF2 in hepatic carcinogenesis (2018) (0)
A Plasma Retinome in School Aged Children of Nepal (2012) (0)
A Plasma Cuprome Exists With Predictors of Copper Status in Nepalese Children (2022) (0)
with Isotope Dilution Mass Spectrometry by ELISA, HPLC with Fluorescence Detection, and HPLC Human Aflatoxin Albumin Adducts Quantitatively Compared (2008) (0)
Working Group members (2015) (0)
Application of monoclonal antibodies to monitor human exposure to aflatoxin B1. (1986) (0)
INTRODUCTION Health of the Bay—Health of People Colloquium, November 13, 1998 (2000) (0)
Title The Plasma Proteome Is Associated with Anthropometric Status of Undernourished Nepalese School-Aged Children Permalink (2017) (0)
Urinary Free Bisphenol a and Bisphenol a Glucuronide Concentrations in a Sample of Neonates in Baltimore, Maryland (2014) (0)
Formation and characterization of a novel 4-hydroxyestradiol-formamidopyrimidine adduct (2008) (0)
Aflatoxin-induced Hepatic Tumorigenesis Transient Intervention with Oltipraz Protects against (2006) (0)
Potential of the Plasma Nutriproteome to Predict Micronutrient Distributions in Undernourished Settings (2015) (0)
Deployment Health Centers Review, 2016-2017 (2017) (0)
Association of Plasma Aflatoxin With Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples From Kenyan Women Enrolled in a Longitudinal Study (2023) (0)
p53 Mutation in Hepatocellular Carcinoma in Northern Thailand (2004) (0)
Abstract PL02-03: Changing landscape of environmental carcinogenesis in Qidong, China: Lessons for prevention (2013) (0)
Chemical carcinogens in the -omics era (2007) (0)
A Plasma Proteome is Associated with Anthropometric Status in School‐aged Children in Nepal (2016) (0)
In Vivo Activation of Aflatoxin B 1 in C 57 BL / 6 N Mice Carrying a Human Fetus-specific CYP 3 A 7 Gene ' (2006) (0)
Abstract IA24: Applying epidemiology to prevention (2020) (0)
Global Discovery and Temporal Changes of Human Albumin Modifications by Pan-Protein Adductomics: Initial Application to Air Pollution Exposure. (2023) (0)
A novel synthetic tricyclic compound with an acetylene group at C-8a and cyano enones in rings A and C is a potent multifunctional agent in vitro and suppresses the formation of aflatoxin-DNA adducts in vivo (2007) (0)
Abstract 603: Signatures of chemoprotection from ambient exposure to outdoor air pollution in the human serum albumin Cys34adductome (2019) (0)
Abstract SY27-01: The changing etiology of liver cancer (2019) (0)
Constructing a Plasma Nutriproteome for Population Assessment: Analytical Considerations (2022) (0)
CHAPTER 1. Human exposure to aflatoxins and fumonisins (2015) (0)
Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non‐alcoholic fatty liver disease? Authors’ reply (2022) (0)
2.15 – Molecular Biomarkers (2010) (0)
Measles, Mumps, and Rubella Booster Immunization Practices (2020) (0)
Environmental Carcinogens and Risk for Human Liver Cancer (2009) (0)
A Plasma Proteome Associated with Inflammation in Nepalese School‐aged Children (2015) (0)
Effects of Antenatal Micronutrient Supplementation on Plasma Protein Profiles in Nepalese Children (2013) (0)
Early Life Metabolism of Bisphenol A: A Systematic Review of the Literature (2014) (0)
Physical/chemical/immunologic analytical methods. (2011) (0)
Longitudinal analysis of aflatoxin and gallbladder cancer (2019) (0)
Immunoaffinity-based biosensor for polycyclic aromatic hydrocarbons (2001) (0)
Plasma Proteome Associated with Hepcidin and Iron Status in 6–8 Year Old Children of Rural Nepal (2016) (0)
Abstract LB-157: Association of aflatoxin and gallbladder cancer in Shanghai (2017) (0)
Contact dermatitis due to thiamine; report of 2 cases. (1950) (0)
Hepatocellular Carcinoma and Aflatoxin Exposure in Zhuqing Village , Fusui County , People ’ s Republic of China 1 (2001) (0)
CHAPTER 7. Intervention strategies to reduce human exposure to aflatoxins and fumonisins (2015) (0)
Plasma proteins and vitamin K (PIVKA‐II) status in school aged children in Nepal (804.22) (2014) (0)
Chapter 29. Translating DNA Adduct Knowledge to Human Prevention Trials (2020) (0)
Determination of Zearalenone in Urine Samples from Guatemala: A Pilot Assessment (2022) (0)
Abstract 4221: Aflatoxin exposure in a population-based representative sample of adults in Mexico in 2018 (2023) (0)
A Plasma α‐Tocopherome in School Aged Children of Nepal (2012) (0)
Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico. (2022) (0)
Aflatoxin B[subscript 1]-DNA adduct formation and mutagenicity in livers of neonatal female B6C3F1 mice (2011) (0)
Abstract PL02-01: Global disparities and prevention strategies in liver cancer (2011) (0)
Novel Plasma Proteins in Nepalese School-aged Children are Associated with a Small Head Size at Birth (2018) (0)
CHAPTER 6. Effects of aflatoxins and fumonisins on the immune system and gut function (2015) (0)
Genotoxicity in Hypersensitive GSTA3 Knockout Mice (2014) (0)
Publication Types, MeSH Terms, Substances, Grant Support (2007) (0)
Abstract 1083: Temporal trends in microRNAs during subchronic aflatoxin dosing and modulation by the chemopreventive oleane triterpenoid, CDDO-Im (2016) (0)
Preparative hplc analysis of the interaction of chloroethyl- -nitrosoureas with the cellular dna of l1210 cells in culture. Abstr. (1983) (0)
CHAPTER 2. Child stunting in developing countries (2015) (0)
Repair Proficient Human Cells Plasmid Replicated in Xeroderma Pigmentosum and DNA-induced Mutations in a 1 Sequence Specificity of Aflatoxin B Updated (2006) (0)
Disclosures of interests (2015) (0)
Abstract SY14-04: Global burden of liver cancer: Emerging needs in Asia. (2013) (0)
Abstract 3679: Modulation of estrogen depurinating DNA adduct by sulforaphane or KEAP1 knockdown in human breast epithelial cells. (2013) (0)
Analysis of TP53 gene mutations demonstrates that aflatoxin is a risk factor for hepatocellular carcinoma in Guatemala (2019) (0)
Changing Etiology and Epidemiology of Human Liver Cancer (2021) (0)
Mycotoxins were not associated with environmental enteropathy in a cohort of Tanzanian children (2022) (0)
A Follow-Up Study of Urinary Markers of Aflatoxin Exposure and Liver Cancer Risk in Shanghai , People ’ s Republic of China 1 (2005) (0)
Eighth international conference on carcinogenesis and risk assessment: “Genetics and susceptibility: Impact on risk assessment” (1995) (0)
Abstract 4448: Elevated levels of circulating miR-34a-5p and miR-181c-3p during cancer initiation by aflatoxin B1 (2017) (0)
Short Oligonucleotide Mass Analysis (SOMA) (2001) (0)
Editorial: higher levels of certain serum bile acids in non‐alcoholic fatty liver disease–new insights from Guatemala.Authors’ reply (2022) (0)

This paper list is powered by the following services:

Other Resources About John Groopman

en.wikipedia.org

What Schools Are Affiliated With John Groopman?

John Groopman is affiliated with the following schools: